ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $30,000 | -30.2% | 10,300 | +82.0% | 0.01% | -33.3% |
| Q2 2019 | $43,000 | -71.7% | 5,659 | -50.9% | 0.01% | -40.0% |
| Q1 2019 | $152,000 | +97.4% | 11,518 | +123.3% | 0.02% | -20.0% |
| Q4 2018 | $77,000 | -26.7% | 5,159 | +35.8% | 0.02% | +4.2% |
| Q2 2018 | $105,000 | +162.5% | 3,800 | +123.5% | 0.02% | +140.0% |
| Q1 2018 | $40,000 | -86.3% | 1,700 | -85.2% | 0.01% | -75.6% |
| Q2 2016 | $293,000 | -70.0% | 11,500 | -68.8% | 0.04% | -63.7% |
| Q1 2016 | $976,000 | +247.3% | 36,900 | +248.1% | 0.11% | +253.1% |
| Q3 2015 | $281,000 | -57.4% | 10,600 | -46.5% | 0.03% | -73.3% |
| Q1 2015 | $660,000 | – | 19,823 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |